Articles published by Cytovance Biologics

Cytovance Biologics Launches In-House Cell Line Development with High-Yield Titers up to 10g/L

Today 9:00 EDT

From Cytovance Biologics

Via Business Wire

Cytovance Biologics Celebrates 20 Years of U.S.-Based Biomanufacturing Excellence in Oklahoma City

November 13, 2025

From Cytovance Biologics

Via Business Wire

Cytovance Biologics Expands Services With In-House Formulation Development

September 03, 2025

From Cytovance Biologics

Via Business Wire

Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

January 13, 2025

From Cytovance Biologics

Via Business Wire

CDMO Cytovance Biologics and CDO Celltheon Partner to Offer a Complete, US-based Platform Solution for mAbs and Difficult-to-Express Proteins

July 30, 2024

From Cytovance Biologics

Via Business Wire

ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture

May 08, 2024

From Cytovance Biologics

Via Business Wire

Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers

December 11, 2023

From Cytovance Biologics

Via Business Wire

Large Molecule CDMO, Cytovance Biologics, and Custom Strain Development Expert, Vectron Biosolutions, Partner to Improve Development of Complex Microbial Molecules

October 10, 2023

From Cytovance Biologics

Via Business Wire

Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing

March 11, 2023

From Cytovance Biologics

Via GlobeNewswire

Cytovance Biologics Announces Ping Zhang as Chief Executive Officer

January 16, 2023

From Cytovance Biologics

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.